Whalesbook
Record Promoter Selling
Promoter selling in Indian listed companies surged to an all-time high of ₹1.5 trillion last year, extending a three-year streak of annual sell-downs exceeding ₹1 trillion. These substantial figures often cause investor unease.
However, seasoned market participants understand that promoter transactions require context. Not every sale signifies distress, and a quieter, more telling counter-trend has emerged. Some promoters are buying shares from the open market, demonstrating conviction in their businesses when uncertainty remains high.
The Counter-Trend: Insider Buying
These transactions are more than mere disclosures; they represent promoters putting fresh capital at risk. This action signals a belief in the upside potential their businesses hold, which the market may not have fully recognized.
This report focuses on four recently listed companies where promoters have been increasing their stakes through open-market purchases, signaling intrinsic value.
Enviro Infra Engineers
Enviro Infra Engineers, specializing in water and wastewater management solutions for municipal and industrial clients, saw its promoters raise their stake to 70.13% in the December 2025 quarter. The company has achieved rapid growth, with sales and net profit compounding at 62% and 102% over five years, respectively. Its order book of approximately ₹20 billion offers nearly two years of revenue visibility.
Indo Farm Equipments
Indo Farm Equipments, a manufacturer of cranes and tractors, reported a promoter stake increase to 69.53% in the December 2025 quarter. The company has a five-year sales and net profit CAGR of 10% and 37%, respectively. Its in-house NBFC, Barota Finance, supports its extensive dealer network and sales ecosystem.
Senores Pharma
Senores Pharma, a research-driven formulations company with a strong focus on regulated markets like the US, saw its promoter stake rise to 45.8% in the December 2025 quarter. Over the past three years, the company has delivered exceptional growth, with sales and net profit compounding at 204% and 289%, respectively.
Suraksha Diagnostic
Suraksha Diagnostic, a leading diagnostic chain in Eastern India, recorded an increase in promoter stake to 48.98% in the December 2025 quarter. The company has achieved consistent sales and net profit growth of 10% and 15% respectively over the past five years, while pursuing inorganic expansion through acquisitions.
Investor Signal
When promoters buy shares in their own companies, it often reflects confidence in long-term prospects, especially during periods of market volatility. This insider buying can be a valuable signal, though investors must also consider fundamentals, governance, and valuations.